ARCHIVES

Grants Funding: FY(& Year-End Report By NCI On Paylines

This article is from The Cancer Letter archive.

Vol. 23 No. 39 | October 10, 1997

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

RFA On Role Of Nutrients In Cancer Prevention

June 3, 1983

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013